Wdr54-KO Mouse
一般名
Wdr54-KO
製品ID
S-KO-18308
背景情報
C57BL/6JCya
系統ID
KOCMP-75659-Wdr54-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Wdr54-KO Mouse(カタログ番号S-KO-18308)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Wdr54-KO
系統ID
KOCMP-75659-Wdr54-B6J-VA
遺伝子名
製品ID
S-KO-18308
遺伝子別名
1700030E05Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 6
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000153148
NCBIトランスクリプトID
NM_023790
ターゲット領域
Exon 3~9
有効領域の大きさ
~2.7 kb
遺伝子研究の概要
Wdr54, a member of the WD40 repeat (WDR) domain-containing protein family, has emerged as an important gene in multiple biological processes and disease conditions. The WD40 repeat domains are known to be involved in various protein-protein interactions, which likely contribute to Wdr54's functions. It may participate in pathways related to cell growth, survival, and metastasis, and is of great significance in understanding cancer development and sperm-oocyte fusion [2,5,6].
In cancer research, studies have shown that Wdr54 is overexpressed in multiple cancers. In T-cell acute lymphoblastic leukemia (T-ALL), depletion of Wdr54 inhibited cell viability, induced apoptosis, and arrested the cell cycle at the S phase, impeding leukemogenesis in a xenograft model. The mechanism may involve down-regulating the expression of PDPK1, phospho-AKT (p-AKT), total AKT, phospho-ERK (p-ERK), Bcl-2 and Bcl-xL, while up-regulating cleaved caspase-3 and cleaved caspase-9. RNA-seq analysis also indicated its role in regulating some oncogenic genes in multiple signaling pathways [1]. In bladder cancer, Wdr54 promoted tumorigenesis, metastasis, and impaired chemosensitivity by preventing the degradation and ubiquitination of MEMO1, promoting the interaction between MEMO1 and IRS1, and activating the IRS1/AKT/β-catenin pathway [4]. In colorectal cancer, knockdown of Wdr54 significantly inhibited cell growth and aggressiveness, and high Wdr54 expression was an independent risk factor for disease-specific survival [5]. In head and neck squamous cell carcinoma (HNSCC), Wdr54 was overexpressed, and its expression increased with disease progression, was associated with metastasis, and patients with high levels had a poorer prognosis [3].
In conclusion, Wdr54 plays oncogenic roles in multiple cancers, affecting cell growth, survival, and metastasis through various signaling pathways. Although no KO/CKO mouse models were mentioned in the provided references, the in vitro and in vivo xenograft studies have clearly demonstrated its significance in cancer-related biological processes. Understanding Wdr54 may provide potential therapeutic targets for these cancers. Additionally, its role in sperm-oocyte fusion reveals its importance in reproductive biology [1,3,4,5,6].
References:
1. Li, Huan, Zhang, Danlan, Fu, Qiuxia, Zhao, Na, Lu, Desheng. 2023. WDR54 exerts oncogenic roles in T-cell acute lymphoblastic leukemia. In Cancer science, 114, 3318-3329. doi:10.1111/cas.15872. https://pubmed.ncbi.nlm.nih.gov/37302808/
2. Maeda, Akane, Nishino, Tasuku, Matsunaga, Ryota, Yagi, Toshiki, Konishi, Hiroaki. 2018. Transglutaminase-mediated cross-linking of WDR54 regulates EGF receptor-signaling. In Biochimica et biophysica acta. Molecular cell research, 1866, 285-295. doi:10.1016/j.bbamcr.2018.11.009. https://pubmed.ncbi.nlm.nih.gov/30458214/
3. Jeong, Eun-Jeong, Kim, Eunjeong, Kim, Yeon Soo. 2024. Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis. In Scientific reports, 14, 32102. doi:10.1038/s41598-024-83680-1. https://pubmed.ncbi.nlm.nih.gov/39739088/
4. Wei, Xiaosong, Wang, Beibei, Wu, Zixin, Zhang, Lirong, Song, Dongkui. 2023. WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity. In Cancer letters, 556, 216058. doi:10.1016/j.canlet.2023.216058. https://pubmed.ncbi.nlm.nih.gov/36627049/
5. Yuan, Yuncang, Qi, Guoxiang, Shen, Hao, Chang, Wenjun, Zheng, Shangyong. 2018. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer. In International journal of cancer, 144, 1584-1595. doi:10.1002/ijc.31736. https://pubmed.ncbi.nlm.nih.gov/29987896/
6. Lai, Xiong, Liu, Ruizhuo, Li, Mengyu, Su, Huimin, Xing, Wanjin. 2023. Participation of WD repeat-containing protein 54 (WDR54) in rat sperm-oocyte fusion through interaction with both IZUMO1 and JUNO. In Theriogenology, 214, 286-297. doi:10.1016/j.theriogenology.2023.10.031. https://pubmed.ncbi.nlm.nih.gov/37951137/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
